Risk Adapted Therapy of Hodgkin Lymphoma in Upper Egypt
NCT06340243 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2024-04-01
Summary
determine if radiotherapy could be safely omitted for early hodgkin lymphoma responder patients without compromising outcome
Conditions
- Pediatric Hodgkin Lymphoma
Interventions
- RADIATION
-
radiotherapy
radiotherapy
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 1 Month
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-04-01
- Primary Completion
- 2026-04-01
- Completion
- 2026-04-01
More Related Trials
-
Low Dose Radiotherapy for Advanced Hidradenitis Suppurativa
NCT03040804 ·Status: TERMINATED ·Phase: NA
-
Registry Study of Proton Radiotherapy in Lymphoma
NCT04613388 ·Status: RECRUITING
-
Post-operative Radiotherapy in Poor Responders Ewing's Sarcoma Patients
NCT01734863 ·Status: WITHDRAWN ·Phase: PHASE3
-
Repeat CT for Evaluation of Inter- and Intrafraction Changes During Curative Thoracic Radiotherapy
NCT03024138 ·Status: COMPLETED
-
Efficacy of Dose Intensified Radiotherapy of Spinal Metastases by Hypofractionated Radiation and IGRT hfSRT Mediated Boost
NCT01849510 ·Status: UNKNOWN ·Phase: PHASE2
-
Hypofractionated Radiotherapy in Breast Cancer
NCT03167359 ·Status: COMPLETED ·Phase: NA
-
Adjuvant Hypofractionation Radiotherapy for Thymic Epithelial Tumours After Complete Resection
NCT06189183 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Localized Osteosarcoma in Upper Egypt: A Clinical Prediction Model
NCT03839095 ·Status: COMPLETED
-
Radiotherapy of Head and Neck Cancer With SIB
NCT06831903 ·Status: RECRUITING
-
Comparison of Proton and Photon Radiotherapy of Brain Tumors (ProtoChoice-Hirn)
NCT02824731 ·Status: RECRUITING ·Phase: NA
-
A Feasibility Study On Continuous Adaptive [18f]Fdg-Pet-Guided Radiotherapy For Head and Neck Cancer
NCT01208883 ·Status: COMPLETED ·Phase: PHASE1
-
Use Feasibility of the iThermonitor in Pediatrics Patients on Myelosuppresive Therapies
NCT02410252 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Palliative Low-Dose Involved-Field Radiation Therapy for Recurrent Advanced Follicular Lymphoma
NCT02438501 ·Status: RECRUITING ·Phase: PHASE3
-
Radioimmunotherapy With 131I-L19SIP in Patients With Cancer
NCT01242943 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Percutaneous Thermal Ablation in Lung Tumors
NCT06891183 ·Status: RECRUITING ·Phase: NA
-
Effectiveness of Stereotactic RadioTherapy in Solid Primary Inoperable and Oligometastatic Cancer
NCT03461822 ·Status: UNKNOWN
-
Radiation Therapy to Treat Musculoskeletal Tumors
NCT00186992 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast Cancer
NCT03345420 ·Status: COMPLETED ·Phase: PHASE2
-
Radiotherapy With Hyperthermia in Recurrent and Radiation-Induced Sarcomas
NCT04398095 ·Status: COMPLETED ·Phase: NA
-
Ledderhose Disease - Long Term Effects of Radiotherapy Treatment. LedRad LTE - Study
NCT04229147 ·Status: COMPLETED
-
Stereotactic Radiosurgery Dose Escalation for Brain Metastases
NCT02390518 ·Status: RECRUITING ·Phase: PHASE1
-
Fractionated Stereotactic Radiotherapy vs. Single Session Radiosurgery in Patients With Larger Brain Metastases
NCT03697343 ·Status: RECRUITING ·Phase: PHASE3
-
Efficacy and Safety of Radiotherapy in Oligoprogressive HCC Following First-line PD-1 Therapy
NCT06870942 ·Status: RECRUITING ·Phase: PHASE2
-
Individualized Response-adaptive Radiation Dose Prescription in HNC Based on MRI
NCT05160714 ·Status: UNKNOWN ·Phase: PHASE1
-
Testing the Safety of Giving a Standard Dose of Radiation Over a Shorter Period of Time for Patients Who Had Surgery for Intermediate-Risk Head and Neck Cancer
NCT05540899 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1